EW vs IRD · P/E 47, rev $1.39B vs rev $11.0M
Edwards Lifesciences Corp (EW) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. IRD currently screens at market cap $35.7M.
Not investment advice. Open the EW and IRD stock pages for the full models.
Not investment advice.